Cianopramine (INN) (developmental code name Ro 11-2465), also known as 3-cyanoimipramine, is a tricyclic antidepressant related to imipramine that acts as a serotonin reuptake inhibitor[1] and weak serotonin receptor antagonist.[2][3] It was investigated for the treatment of depression but was never marketed.[3]
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H23N3 |
| Molar mass | 305.425 g·mol−1 |
| 3D model (JSmol) | |
| |
See also
editReferences
edit- ^ Kenny M, Lenehan TJ, Lambe R, Darragh A, Brick I, Omer LM (1983). "Effects of a single oral dose of 3-cyano-imipramine on serotonin uptake and content of platelets in healthy volunteers". Psychopharmacology. 79 (4): 304–7. doi:10.1007/bf00433406. PMID 6407042. S2CID 3112636.
- ^ Pawłowski L, Kwiatek H, Górka Z (1981). "Is Ro 11-2465 (cyan-imipramine) an antagonist of postsynaptic serotonin receptors?". Journal of Neural Transmission. 52 (1–2): 61–72. doi:10.1007/BF01253098. PMID 7288439. S2CID 41042435.
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 270–. ISBN 978-1-4757-2085-3.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |